Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions

In this week's Pharma Pulse, USP's annual shortages report reveals a sharp rise in drug discontinuations, J&J and Roche commit billions to protein degrader platforms, and more.